Flow cytometry analysis of tumor-infiltrating immune cells showed that Pin1 inhibitor monotherapy increased infiltration of CD3+ lymphocytes, CD8+ T cells, and CD4+ T cells. This evidence concerns the gene CD4 and neoplasm.